GeoVax Collaborators

Partnering with GeoVax
GeoVax is constantly seeking to expand and improve its vaccine and immunotherapy pipeline.  We seek to maximize the impact of our vaccine formulation and development expertise by partnering with leading academic institutions, government agencies, and pharmaceutical companies.If you are interested in learning more about our MVA-VLP platform technology or partnership opportunities, please contact us at
Current and Past Collaborators
Our goal is to advance products through to human clinical testing, and to seek partnership or licensing arrangements for achieving regulatory approval and commercialization. We also leverage third party resources through collaborations and partnerships for preclinical and clinical testing with multiple government, academic and corporate entities. Below is a partial list of our current and past collaborators that have supported our development programs.
Development Programs and Collaborators
Register to receive email alerts for GeoVax press releases
Copyright © GeoVax 2021. All Rights Reserved.